Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

3.83
Delayed Data
As of May 18
 -0.03 / -0.78%
Today’s Change
3.22
Today|||52-Week Range
7.95
-17.10%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close3.86
Today’s open3.84
Day’s range3.79 - 3.95
Volume275,259
Average volume (3 months)656,649
Market cap$116.9M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+53.44%
Earnings growth (this year)-16.07%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)+4,327.38%
P/E ratioNM
Price/Sales3.73
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...+0.35+8.05%
VRNAVerona Pharma PLC-0.57-3.46%
SMMTSummit Therapeutics ...+0.02+0.14%
NTECIntec Pharma Ltd0.000.00%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$35.4M
Annual profit (last year)-$17.4M
Net profit margin-49.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts